As a hub for biomedical innovation, Massachusetts brings together an industry and community of hospitals, biotechnology companies, venture capitalists, universities, and entrepreneurs, employing more than 65,000 people in this space. David Torchiana, MD, President and CEO of Partners HealthCare and Jeffrey Leiden, MD, PhD, Chairman, President and CEO of Vertex Pharmaceuticals recently shared their thoughts with The Boston Globe and WBUR about the biomedical ecosystem here in Massachusetts and what potential cuts to National Institutes of Health (NIH) funding may mean for the state.

Read the op-ed in the Boston Globe or listen to their interview with WBUR Radio Boston.